Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON45029Recruiting
Single-arm trial of Neobella, sponsored by Amsterdam University Medical Center. Primary endpoints: Postprandial insulin concentration in plasma and Postprandial bile acid concentration in plasma. Started Sep 2013; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON45029.